ArticleCancer management and research2021

Erratum: Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.